The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Novo Nordisk Pharma Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 147,700,000 PLN
2021 - 169,700,000 PLN
2022 - 236,000,000 PLN
2023 - 329,500,000 PLN
2024 - 416,600,000 PLN
+ workforce (estimated if not reported)
2024 - 400
+ depreciation & amortization
2020 - 400,300 PLN
2021 - 411,000 PLN
2022 - 446,400 PLN
2023 - 461,100 PLN
2024 - 560,200 PLN
Novo Nordisk Pharma is a subsidiary of the Danish pharmaceutical giant, specializing in innovative treatments for diabetes, hemophilia, and hormonal therapies. It has been operating in Poland since 2002, employing over 50 people and focusing on research, development, and manufacturing of pharmaceutical products.